Home / Inspections / 1054711

FDA Inspection 1054711 — Megafine Pharma (P) Limited

Megafine Pharma (P) Limited — FEI 3005694111

The FDA completed an inspection of Megafine Pharma (P) Limited on May 12, 2018 in Nashik. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
May 12, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Nashik (India)

Facility

Other inspections at this facility

  • 1195646 (VAI Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1122874 (OAI Fri Mar 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 929021 (OAI Fri May 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 730085 (NAI Thu Jun 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources